241 related articles for article (PubMed ID: 26220267)
1. Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation.
Gorla R; Erbel R; Kuehl H; Kahlert P; Tsagakis K; Jakob H; Mahabadi AA; Schlosser T; Bockisch A; Eggebrecht H; Bossone E; Jánosi RA
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1677-85. PubMed ID: 26220267
[TBL] [Abstract][Full Text] [Related]
2. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
3. Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation.
Kuehl H; Eggebrecht H; Boes T; Antoch G; Rosenbaum S; Ladd S; Bockisch A; Barkhausen J; Erbel R
Heart; 2008 Nov; 94(11):1472-7. PubMed ID: 18070949
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
[TBL] [Abstract][Full Text] [Related]
5. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
6. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters.
Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
8. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Tezuka D; Haraguchi G; Ishihara T; Ohigashi H; Inagaki H; Suzuki J; Hirao K; Isobe M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):422-9. PubMed ID: 22498333
[TBL] [Abstract][Full Text] [Related]
9. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
[TBL] [Abstract][Full Text] [Related]
12.
Bouter C; Braune I; Meller B; Sahlmann C; Ritter C; Meller J
Nuklearmedizin; 2016 Dec; 55(6):242-249. PubMed ID: 27617327
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
14. The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery.
Guenther SP; Cyran CC; Rominger A; Saam T; Kazmierzcak PM; Bagaev E; Pichlmaier M; Hagl C; Khaladj N
Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):450-8. PubMed ID: 26174118
[TBL] [Abstract][Full Text] [Related]
15. Relationship between inflammation and progression of an abdominal aortic aneurysm in a rabbit model based on 18F-FDG PET/CT imaging.
Nie MX; Zhang XH; Yan YF; Zhao QM
Vascular; 2018 Dec; 26(6):571-580. PubMed ID: 29673292
[TBL] [Abstract][Full Text] [Related]
16. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
Kuzniar M; Tegler G; Wanhainen A; Ahlström H; Mani K; Hansen T
Eur J Vasc Endovasc Surg; 2020 Mar; 59(3):464-471. PubMed ID: 31708339
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of (18)F-FDG PET/CT in inflammation of unknown origin.
Balink H; Bennink RJ; Veeger NJ; van Eck-Smit BL; Verberne HJ
Clin Nucl Med; 2014 May; 39(5):419-25. PubMed ID: 24662652
[TBL] [Abstract][Full Text] [Related]
19. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
